John Jacobsen
Keine laufenden Positionen mehr
Profil
John Jacobsen worked as a Senior Director-Medicinal Chemistry at Theravance Biopharma, Inc. from 1998 to 2015.
He then worked as the Chief Scientific Officer at DiCE Therapeutics, Inc. from 2021 to 2023.
Prior to his career, he earned an undergraduate degree from Harvard College and a doctorate from the University of California, Berkeley.
Ehemalige bekannte Positionen von John Jacobsen
| Unternehmen | Position | Ende |
|---|---|---|
| DICE THER | Chief Tech/Sci/R&D Officer | 09.08.2023 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01.10.2015 |
Ausbildung von John Jacobsen
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
